Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation , 2015, we hereby inform you that the Board of Directors of the Company, at its meeting ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Rekvina Laboratories Ltd has appointed Mr. Jay Chintan Patel (DIN: 10147916) as an Additional Non-Executive Independent Director on the Board, effective 29th January 2026. The appointment was approved at a Board meeting held on the same day and is for a term of 5 years, running until 28th January 2031, subject to shareholder approval. Mr. Patel is the Founder and Director of Duchas Technologies Private Limited, a DPIIT-recognised startup focused on AI, biometrics, and digital products. The company confirmed he is not debarred by SEBI and is not related to any existing Director of the company.
This is a routine board appointment to strengthen the independent director lineup, with no immediate material impact on the stock price. Investors may view the addition of a technology-focused director as a positive signal for digital or innovation-driven growth, but it is a standard governance disclosure.